TLSA (Tiziana Life Sciences) Other Current Receivables: $4.26 Mil (As of Dec. 2025)


TLSA Tiziana Life Sciences Ltd TLSA
26 GF Score
Price $1.31
! 2 Warning Signs
View Full Analysis

What is Tiziana Life Sciences Other Current Receivables?

Tiziana Life Sciences TLSA +4.80% 26 Other Current Receivables is $4.26 Mil as of Dec. 2025. GuruFocus rates TLSA with a GF Score™ of 26/100. The stock has 2 warning signs investors should review.

Tiziana Life Sciences's Other Current Receivables for the quarter that ended in Dec. 2025 was $4.26 Mil.

Tiziana Life Sciences's quarterly Other Current Receivables increased from Dec. 2024 ($3.69 Mil) to Jun. 2025 ($5.47 Mil) but then stayed the same from Jun. 2025 ($5.47 Mil) to Dec. 2025 ($4.26 Mil).

Tiziana Life Sciences's annual Other Current Receivables declined from Dec. 2023 ($6.05 Mil) to Dec. 2024 ($3.69 Mil) but then increased from Dec. 2024 ($3.69 Mil) to Dec. 2025 ($4.26 Mil).

Tiziana Life Sciences Other Current Receivables Related Terms

Tiziana Life Sciences Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Tiziana Life Sciences's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tiziana Life Sciences Other Current Receivables Chart

Tiziana Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.27 5.99 6.05 3.69 4.26

Tiziana Life Sciences Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.05 6.62 3.69 5.47 4.26
TLSA
26GF Score
Tiziana Life Sciences Ltd TLSA
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tiziana Life Sciences Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $4.26 Mil mean?
Tiziana Life Sciences (TLSA) has a Other Current Receivables of $4.26 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Tiziana Life Sciences and its competitors.
Is Tiziana Life Sciences' Other Current Receivables too high?
Tiziana Life Sciences' current Other Current Receivables is $4.26 Mil. Overall, Tiziana Life Sciences has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Tiziana Life Sciences' Other Current Receivables compare to SPRB and MIST?
Tiziana Life Sciences' Other Current Receivables of $4.26 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Tiziana Life Sciences and its competitors. Tiziana Life Sciences's current Other Current Receivables is $4.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tiziana Life Sciences stock overvalued right now?
Tiziana Life Sciences (TLSA) has a current Other Current Receivables of $4.26 Mil. The current Other Current Receivables is $4.26 Mil. Tiziana Life Sciences' overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Tiziana Life Sciences (TLSA), the current Other Current Receivables is $4.26 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tiziana Life Sciences Business Description

Other Exchanges 0RP:Germany
Address 2 Church Street, Clarendon House, Hamilton, BMU, HM 11
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.
26GF Score

Get the complete analysis for TLSA

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.31
Price